Table 3.

Estimated absolute risk differences between the antithrombin group and control group using the overlap weighting method.

Outcomes	Absolute Risk Difference †	p Value
Primary outcome
PICS or mortality on day 14	−3.1 (−9.3 to 3.2)	0.335
PICS on day 14	−1.1 (−7.5 to 5.4)	0.747
14-day mortality	−2.3 (−6.6 to 2.0)	0.295
Secondary outcomes
PICS or mortality on day 28	−4.9 (−11.3 to 1.5)	0.134
PICS on day 28	1.2 (−4.7 to 7.0)	0.695
28-day mortality	−6.6 (−11.5 to −1.7)	0.008
In-hospital mortality	−9.5 (−15.2 to −3.8)	0.001

PICS, persistent inflammation, immunosuppression. ^† Absolute risk differences were presented as percentages with 95% confidence intervals.